Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virchow Medical is a precision oncology company specializing in "biopsy specimen stewardship" to maximize the utility of patient biological material for genomic testing. The company develops proprietary collection devices, most notably the Crow's Nest Biopsy Catchment System, which captures tumor cells and genetic material that are typically discarded as medical waste during core needle biopsies. These "Liquid Companion Specimens" (LCSs) are stored in the Virchow Vault, a unique biorepository and data library that enables comprehensive genomic sequencing and multi-omic analysis. By providing high-quality molecular data from otherwise wasted resources, Virchow Medical helps clinicians identify targeted therapy options for cancer patients and supports biopharma partners in biomarker discovery and drug development. The company's mission is to ensure that every biopsy patient has the opportunity to benefit from precision medicine by overcoming tissue insufficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virchow Medical.